XORTX Therapeutics Inc
Change company Symbol lookup
Select an option...
XRTX XORTX Therapeutics Inc
TRAA Traack Technologies Inc
HRL Hormel Foods Corp
GTBP GT Biopharma Inc
UNH UnitedHealth Group Inc
BAC Bank of America Corp
WSO Watsco Inc
LITB LightInTheBox Holding Co Ltd
CVCY Central Valley Community Bancorp
AFAQU AF Acquisition Corp
Go


Based in Canada
Company profile

XORTX Therapeutics Inc. is a Canada-based pharmaceutical company. The Company is focused on identifying, developing and commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan disease indications, such as autosomal dominant polycystic kidney disease (ADPKD) and type 2 diabetic nephropathy (T2DN) as well as acute kidney injury (AKI) due to coronavirus infection. Its lead product candidates are XRx-008, XRx-101 and XRx-225. XRx-008 is a late clinical stage program focused on demonstrating the potential of its therapy for ADPKD. XRx-101 is a program to treat acute kidney injury associated with Coronavirus/ COVID-19 infection, AKI and associated health consequences. XRx-225 is a program for the treatment of T2DN. It is also working to advance its clinical development stage products that target aberrant purine metabolism and xanthine oxidase to decrease or inhibit production of uric acid.

Closing Price
$1.43
Day's Change
-0.02 (-1.38%)
Bid
--
Ask
--
B/A Size
--
Day's High
1.53
Day's Low
1.43
Volume
(Light)
Volume:
8,034

10-day average volume:
570,236
8,034
  • Prev Close
    1.45
  • Today's Open
    1.53
  • Day's Range
    1.43-1.53
  • Avg Vol (10-day)
    570.2K
  • Last (time)
    4:00p ET 05/17/22
  • Last (size)
    155
  • 52-Wk Range
    0.9615 - 8.19
    LowHigh
  • (06/10/21 - 09/08/21)
    48.72%
  • 141.4%
  • Market Cap
    18.6M
  • Shares Outstanding
    13.0M
  • -0.44
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.4
  • 8.17
  • (% of float 04/29/22)
    0.11

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.